LAVA Therapeutics

+$0.11 (+4.01%) Today
+$0.15 (+5.26%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell LVTX and other ETFs, options, and stocks.

About LVTX

LAVA Therapeutics NV operates as an immuno-oncology company. It utilizing its proprietary Gammabody platform to develop a portfolio of bispecific gamma delta T cell engagers for the potential treatment of solid tumors and hematological malignancies.

CEO
Stephen Allen Hurly
Employees
58
Headquarters
Utrecht, Noord-Brabant
Founded
2016

LVTX Key Statistics

Market cap
73.46M
Price-Earnings ratio
—
Dividend yield
—
Average volume
10.64K
High today
$3.11
Low today
$2.80
Open price
$2.80
Volume
11.31K
52 Week high
$11.80
52 Week low
$2.74

LVTX Earnings

-$12.29
-$8.19
-$4.10
$0.00
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Estimated
— per share
Actual
-$0.41 per share
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure